Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy-induced nausea and vomiting.

Catherine M Bender1, Roxanne W McDaniel, Kathleen Murphy-Ende

  • 1University of Pittsburgh School of Nursing, 3500 Victoria Street, Room 415, Victoria Building, Pittsburgh, PA 15261, USA. cbe100@pitt.edu

Clinical Journal of Oncology Nursing
|March 14, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The relationship of neighborhood socioeconomic disadvantage and pretreatment cancer-related cognitive impairment in women with breast cancer: A post hoc analysis of a randomized controlled trial.

Cancer·2026
Same author

Caregivers' Perspectives on Cancer-Related Cognitive Impairment in Older Adults With Acute Myeloid Leukemia Receiving Chemotherapy.

Oncology nursing forum·2026
Same author

Developing the multidisciplinary and multispecialty workforce and the systems needed to sustain high-quality care from diagnosis through long-term survivorship.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Barriers to the Adoption of Healthy Lifestyle Behaviors in Patients With Cancer: Results of a National Survey.

JCO oncology practice·2026
Same author

Associations of BDNF methylation and rs6265 genotype with cognitive response to a six-month aerobic exercise intervention in women with early-stage breast cancer: results from the EPICC Trial.

GeroScience·2025
Same author

<i>APOE</i> ε4 Allele and Methylation Patterns Linked to Cardiovascular Outcomes in Women With Breast Cancer.

Biological research for nursing·2025

Chemotherapy-induced nausea and vomiting (CINV) affects up to 60% of patients. This review explores current pharmacologic and behavioral strategies to manage these challenging chemotherapy side effects.

Area of Science:

  • Oncology
  • Pharmacology
  • Patient Symptom Management

Background:

  • Nausea and vomiting (N&V) are significant, distressing side effects of cancer chemotherapy.
  • Despite advancements in antiemetic medications, a substantial percentage of patients (up to 60%) still experience N&V.
  • Accurate incidence data for chemotherapy-induced nausea and vomiting (CINV) is challenging due to patient variability and treatment regimens.

Purpose of the Study:

  • To review the current scientific understanding of chemotherapy-induced nausea and vomiting (CINV).
  • To examine and synthesize effective pharmacologic interventions for managing CINV.
  • To explore evidence-based behavioral strategies for alleviating chemotherapy-related N&V.

Main Methods:

  • Literature review of scientific studies on chemotherapy-induced nausea and vomiting.

Related Experiment Videos

  • Analysis of pharmacologic agents used for antiemesis in cancer patients.
  • Evaluation of behavioral interventions for managing chemotherapy side effects.

    • Main Results:

    • Existing antiemetic therapies, while improved, do not fully eliminate N&V for all patients.
    • A combination of pharmacologic and behavioral approaches shows promise in managing CINV.
    • Further research is needed to refine treatment protocols and improve patient outcomes.

    Conclusions:

    • Chemotherapy-induced nausea and vomiting remains a prevalent and challenging side effect.
    • A comprehensive management strategy integrating pharmacologic and behavioral interventions is crucial.
    • Continued investigation into novel treatments and supportive care is essential for improving quality of life during cancer therapy.